Filing Details
- Accession Number:
- 0000902664-17-004377
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-11-16 14:44:22
- Reporting Period:
- 2017-11-16
- Accepted Time:
- 2017-11-16 14:44:22
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1576263 | Mirati Therapeutics Inc. | MRTX | Pharmaceutical Preparations (2834) | 462693615 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1633313 | Venbio Select Advisor Llc | 120 West 45Th Street Suite 2802 New York NY 10036 | No | No | Yes | No | |
| 1701815 | Behzad Aghazadeh | C/O Venbio Select Advisor Llc 120 W. 45Th Street, 28Th Floor New York NY 10036 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 Par Value Per Share (The "Common Stock" | Acquisiton | 2017-11-16 | 650,000 | $13.00 | 4,360,601 | No | 4 | P | Indirect | See footnotes |
| Common Stock | Acquisiton | 2017-11-16 | 37,500 | $7.86 | 4,398,101 | No | 4 | X | Indirect | See footnotes |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | See footnotes |
| No | 4 | X | Indirect | See footnotes |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Warrant (right to buy) | Disposition | 2017-11-16 | 37,500 | $0.00 | 37,500 | $7.86 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2017-11-21 | No | 4 | X | Indirect |
Footnotes
- The securities reported herein are held on behalf of accounts managed by venBio Select Advisor LLC, a Delaware limited liability company (the "Investment Manager") and venBio Select Fund LLC, a Delaware limited liability company, a fund managed by the Investment Manager. Behzad Aghazadeh ("Dr. Aghazadeh," and together with the Investment Manager, the "Reporting Persons") serves as the portfolio manager and controlling person of the Investment Manager.
- The filing of this statement shall not be deemed an admission that either of the Reporting Persons is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein.
- These warrants can be exercised at any time before the expiration date.
Billionaire Hedge Funds
